New legal framework on Sars-Cov-2 antigen self-tests
Ordinance No. 56/2021 of March 12 established an exceptional and temporary regime for the performance of rapid antigen tests, intended by its manufacturers to be performed in samples of the internal anterior nasal area.
Did you find this article useful?
Download PDF